Home/Hedge Fund Intelligence/Damora Therapeutics, Inc.
Nasdaq: DMRAStockForm 13F30 Jun 2026

Hedge funds that hold Damora Therapeutics, Inc. Nasdaq: DMRA

CUSIP 36322Q206 · who reports it, how much, and how much it matters to them

15 of the 720 hedge fund managers we track reported shares of Damora Therapeutics, Inc. (Nasdaq: DMRA) on Form 13F for 30 June 2026. Between them they reported USD 587m. The largest position belongs to Fairmount Funds Management, at USD 227m.

Managers reporting it15of 720 we track
Value they reportUSD 587mshares only, 30 Jun 2026
Funds they run157with a file on PPLI.com
Largest positionUSD 227mFairmount Funds Management
Typical weight0.1%median share of a manager's book
Heaviest weight15.0%Fairmount Funds Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

15 managers, USD 587m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Damora Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Fairmount Funds Management2 funds on PPLI.comUSD 227m15.0%
2Avoro Capital Advisors1 fund on PPLI.comUSD 98m0.9%
3Ra Capital Management1 fund on PPLI.comUSD 62m0.5%
4Viking Global Investors4 funds on PPLI.comUSD 60m0.2%
5Braidwell12 funds on PPLI.comUSD 42m1.6%
6Balyasny Asset Management25 funds on PPLI.comUSD 32m0.0%
7Perceptive Advisors6 funds on PPLI.comUSD 32m0.5%
8Cormorant Asset Management1 fund on PPLI.comUSD 26m1.3%
9Citadel Advisors32 funds on PPLI.comUSD 4.3m0.0%
10POINT72 Asset Management17 funds on PPLI.comUSD 1.3m0.0%
11Adage Capital Management1 fund on PPLI.comUSD 1.3m0.0%
12Verition Fund Management3 funds on PPLI.comUSD 316,0000.0%
13Squarepoint Ops7 funds on PPLI.comUSD 303,0000.0%
14Two Sigma Investments35 funds on PPLI.comUSD 237,0000.0%
15Persistent Asset Partners10 funds on PPLI.comUSD 210,0000.1%
Next: where it matters most
Where it matters most

For Fairmount Funds Management it is 15.0% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Fairmount Funds ManagementUSD 227m15.0%
2BraidwellUSD 42m1.6%
3Cormorant Asset ManagementUSD 26m1.3%
4Avoro Capital AdvisorsUSD 98m0.9%
5Ra Capital ManagementUSD 62m0.5%
6Perceptive AdvisorsUSD 32m0.5%
7Viking Global InvestorsUSD 60m0.2%
8Persistent Asset PartnersUSD 210,0000.1%
9Balyasny Asset ManagementUSD 32m0.0%
10Adage Capital ManagementUSD 1.3m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Damora Therapeutics, Inc.

What is the ticker symbol of Damora Therapeutics, Inc.?

Damora Therapeutics, Inc. trades under the symbol DMRA on the Nasdaq. Its CUSIP, the code used on Form 13F, is 36322Q206.

Which hedge funds own Damora Therapeutics, Inc. (Nasdaq: DMRA)?

15 of the 720 hedge fund managers PPLI.com tracks reported Damora Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Fairmount Funds Management (USD 227m), Avoro Capital Advisors (USD 98m), Ra Capital Management (USD 62m), Viking Global Investors (USD 60m) and Braidwell (USD 42m).

How many hedge funds hold Damora Therapeutics, Inc.?

15 managers in our coverage reported it, and between them they run 157 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Damora Therapeutics, Inc.?

Fairmount Funds Management, where the position was 15.0% of the reported 13F book at 30 June 2026.

Does this show who is short Damora Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Damora Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.